Clinical trial
Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients…
NCT00308360 · Nathan Kline Institute for Psychiatric Research, Other · Completed
Key facts
| NCT number | NCT00308360 |
|---|---|
| Title | Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility |
| Official title | Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility |
| Lead sponsor | Nathan Kline Institute for Psychiatric Research, Other |
| Collaborators | Janssen, LP Industry Research Foundation for Mental Hygiene, Inc. |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Risperidone, divalproex |
| Enrollment | 46 |
| Start date | Sep 1, 1999 |
| Completion | Apr 1, 2004 |
| First posted | Mar 29, 2006 |
| Last update posted | Mar 29, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: